Allergan 8-K Regulation FD Disclosure

Exhibit 99.1

Actavis Pharma Segment Revenue

(Unaudited; $ in millions)	Six Months Ended June 30, 2014		Three Months Ended June 30, 2014		Three Months Ended March 31, 2014		Twelve Months Ended December 31, 2013		Three Months Ended December 31, 2013		Three Months Ended September 30, 2013		Three Months Ended June 30, 2013		Three Months Ended March 31, 2013		Twelve Months Ended December 31, 2012		Twelve Months Ended December 31, 2011
North American Brands
Lo Loestrin® Fe	$	130.4	$	68.0	$	62.4	$	63.3	$	63.3	$	—	$	—	$	—	$	—	$	—
Minastrin® 24 Fe		104.4		56.5		47.9		55.7		55.7		—		—		—		—		—
Estrace® Cream		111.2		57.9		53.3		60.7		60.7		—		—		—		—		—
Other Women’s Health		97.4		48.4		49.0		113.1		44.9		26.9		21.3		20.0		61.9		32.5
Women’s Health		443.4		230.8		212.6		292.8		224.6		26.9		21.3		20.0		61.9		32.5
Rapaflo®		56.5		25.3		31.2		96.5		25.8		26.8		21.3		22.6		71.1		55.6
Delzicol®/Asacol® HD		277.2		136.4		140.8		150.2		150.2		—		—		—		—		—
Other Urology/Gastroenterology		106.0		52.8		53.2		162.1		60.1		33.4		34.5		34.1		146.6		153.4
Urology/Gastroenterology		439.7		214.5		225.2		408.8		236.1		60.2		55.8		56.7		217.7		209.0
Doryx®		29.4		17.5		11.9		31.0		31.0		—		—		—		—		—
Actonel®		115.3		54.2		61.1		63.1		63.1		—		—		—		—		—
Other Dermatology/Established Brands		153.4		70.2		83.2		266.8		80.3		65.9		67.7		52.9		198.6		190.6
Dermatology/Established Brands		298.1		141.9		156.2		360.9		174.4		65.9		67.7		52.9		198.6		190.6
Total North American Brands		1,181.2		587.2		594.0		1,062.5		635.1		153.0		144.8		129.6		478.2		432.1
North American Generics		2,055.6		1,031.4		1,024.2		3,915.7		1,033.1		976.1		949.8		956.7		3,472.2		2,945.6
International		1,268.3		621.6		646.7		2,502.5		728.1		576.8		619.4		578.2		978.1		430.5
Net Revenues	$	4,505.1	$	2,240.2	$	2,264.9	$	7,480.7	$	2,396.3	$	1,705.9	$	1,714.0	$	1,664.5	$	4,928.5	$	3,808.2

Our North American Brands Revenue consists of three categories: Women’s Health, Urology/Gastroenterology, and Dermatology/Established Brands. The products that make up each category are as follows:

Women’s Health	Urology/Gastroenterology	Dermatology/Established Brands
Atelvia®	Androderm®	Cordran® Tape	Tri-Norinyl®
Crinone®	Asacol®	Doryx®	Oxytrol®
Estrace® Cream	Asacol® HD/Asacol® 800	Actonel®	Gelnique®
Generess® Fe	Delzicol®	Actonel DR®	Sodium Ferric Gluconate
Lo Loestrin® Fe	Enablex®	INFeD®	Actigall®
Loestrin® 24 Fe	Rapaflo®	Kadian®	Condylox®
Minastrin® 24 Fe	Trelstar®	Alora®	Fioricet®
Fibristal™	AndroGel® Copromotion Revenue	Brevicon®	Fiorinal®
		ella®	Norco®
		Estrace® Tablets	Microzide®
		Femring®	Femcon® Fe
		Norinyl®	femhrt®
		Nor-QD®	Sarafem®
		PapSure®	Estrostep® Fe
		PreQue 10™	Ovcon®
			Royalty, Supply & Other Revenue